[1]. Liver function effects of SGLT2 inhibitor and GLP-1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study).
Journal of diabetes investigation (2025年) [査読] 有
[DOI] [2]. Glucagon change rate after glucose load: a potential key for tailoring treatment in gestational diabetes mellitus.
Diabetology international [巻]16 [号]2 [頁]348 -355 (2025年) [査読] 有
[3]. Association between muscle fatigability and diabetic kidney disease complications in patients with type 2 diabetes
JOURNAL OF DIABETES AND ITS COMPLICATIONS [巻]39 [号]2 (2025年) [査読] 有
[DOI] [4]. Verification of the Reliability of an Automated Urine Test Strip Colorimetric Program Using Colorimetric Analysis: Survey Study.
JMIR formative research [巻]9 [頁]e62772 (2025年) [査読] 有
[5]. 【糖尿病治療薬のチョイス!-こんなとき,あんなとき】一歩進んだ薬剤のチョイス シックデイのときの糖尿病治療薬のチョイス
Medicina (株)医学書院 [巻]62 [号]1 [頁]128 -128-132 (2025年) [査読] 無
[DOI]